Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-06-004897
Filing Date
2006-03-13
Accepted
2006-03-13 16:55:58
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f18354e10vk.htm 10-K 815818
2 EXHIBIT 3.2 f18354exv3w2.htm EX-3.2 5610
3 EXHIBIT 10.12 f18354exv10w12.htm EX-10.12 1048132
4 EXHIBIT 12.1 f18354exv12w1.htm EX-12.1 24838
5 EXHIBIT 21.1 f18354exv21w1.htm EX-21.1 1678
6 EXHIBIT 23.1 f18354exv23w1.htm EX-23.1 8754
7 EXHIBIT 31.1 f18354exv31w1.htm EX-31.1 17358
8 EXHIBIT 32.1 f18354exv32w1.htm EX-32.1 4579
9 GRAPHIC f18354f1835400.gif GRAPHIC 59526
  Complete submission text file 0000950134-06-004897.txt   2010329
Mailing Address 500 FORBES BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 500 FORBES BOULEVARD SOUTH SAN FRANCISCO CA 94080 6502663000
CELL GENESYS INC (Filer) CIK: 0000865231 (see all company filings)

EIN.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19986 | Film No.: 06682660
SIC: 2834 Pharmaceutical Preparations